Submitted by Anonymous (not verified) on 26 August 2025 - 14:36
Human medicines European public assessment report (EPAR): Bosulif, bosutinib, Date of authorisation: 27/03/2013, Revision: 27, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Bosulif, bosutinib, Date of authorisation: 27/03/2013, Revision: 27, Status: Authorised